Clinical Trial Update: Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating sequential paclitaxel plus cisplatin chemotherapy followed by radiotherapy as first-line treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Shen Lin | Conditions: Esophageal Squamous Cell Cancer | Phase 2 | Status: UNKNOWN